Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease : a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Gauthier, S, Feldman, H H, Schneider, L S, Wilcock, G K, Frisoni, G B, Hardlund, J H, Moebius, H J, Bentham, P, Kook, K A, Wischik, D J, Schelter, B O, Davis, C S, Staff, R T, Bracoud, L, Shamsi, K, Storey, J M D, Harrington, C R & Wischik, C M 2016, 'Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease : a randomised, controlled, double-blind, parallel-arm, phase 3 trial ', The Lancet, vol. 388, no. 10062, pp. 2873-2884. https://doi.org/10.1016/S0140-6736(16)31275-2